Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
2
×
national blog main
alprazolam
amgen
boehringer ingelheim
boston blog main
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
drug enforcement administration
empagliflozin
europe
europe blog main
europe top stories
indiana
lasmiditan
migraine research foundation
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
slgt2 inhibitor
teva pharmaceutical
triptans
type 1 diabetes
type 2 diabetes
What
approval
drug
eli
2
×
fda
lilly
acute
addresses
bid
boehringer
causes
condition
decades
diabetes
expand
fallen
friday
giant
giving
ingelheim
lasmiditan
lilly’s
marketed
medication
medicine’s
migraine
new
oks
patients
pharmaceutical
rejects
second
short
type
won
Language
unset
2
×
Current search:
eli
×
unset
×
" life sciences "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
